| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785934 | Cancer Treatment Reviews | 2018 | 30 Pages |
Abstract
EGFR-overexpression appears to be associated with reduced OS and DFS in women with early breast cancer. Patients with triple negative and EGFR-overexpression have poorer OS and DFS than those with triple negative tumors and normal EGFR expression.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Galileo A. Gonzalez-Conchas, Laura Rodriguez-Romo, David Hernandez-Barajas, Juan F. Gonzalez-Guerrero, Ivan A. Rodriguez-Fernandez, Adrian Verdines-Perez, Arnoud J. Templeton, Alberto Ocana, Bostjan Seruga, Ian F. Tannock, Eitan Amir,